BioAmber Announces RQecord Revenues for the Second Quarter 2017

- August 3rd, 2017

BioAmber (NYSE:BIOA; TSX:BIOA) has announced operational and financial results for the three months ended June 30, 2017. As quoted in the press release: “We are pleased to report our second quarter 2017 results generated BioAmber’s largest quarterly revenue ever. Year to date we have experienced the greatest acceleration in new customers and new applications since … Continued

BioAmber (NYSE:BIOA; TSX:BIOA) has announced operational and financial results for the three months ended June 30, 2017.
As quoted in the press release:

“We are pleased to report our second quarter 2017 results generated BioAmber’s largest quarterly revenue ever. Year to date we have experienced the greatest acceleration in new customers and new applications since our Sarnia facility was commissioned. Investments in our customer base are resulting in increased sales. Our pipeline is robust and we believe provides us with a solid foundation for 2018” said Mike Hartmann, President of BioAmber Sarnia and Head of Global Sales.
BioAmber also entered into a definitive agreement to purchase Mitsui & Co., Ltd.’s (“Mitsui”) entire minority equity position in the Sarnia manufacturing joint venture. Following the closing of the transaction, BioAmber Inc. will own 100% of the BioAmber Sarnia production facility. Mitsui’s divestiture of their equity stake in the Sarnia joint venture follows a review of their previously announced corporate strategy. Mitsui will still continue to distribute BioAmber’s bio-succinic acid in Asiaand other markets.
Given Mitsui’s longstanding presence in Canada and its shareholding in BioAmber Inc., the parties negotiated terms that allowed Mitsui to achieve its corporate objectives while enabling BioAmber Inc. to assume full ownership of the Sarnia facility.
“This transaction is a meaningful opportunity for BioAmber shareholders”, said Fabrice Orecchioni, BioAmber’s President and COO. “Now that the Sarnia plant is ramping up, full ownership enables BioAmber to retain 100% of projected profits and explore new opportunities with potential partners for the Sarnia facility while continuing to benefit from Mitsui’s marketing and distribution capabilities, especially in Asia.”

Click here to read the full press release.

Experts forecast the cleantech market will reach US$350 billion in 2020.

 
Read your FREE 2020 market report!

Get the latest Cleantech Investing stock information

Get the latest information about companies associated with Cleantech Investing Delivered directly to your inbox.

Cleantech Investing

Select None
Select All

Leave a Reply